[ad_1]
Last month, Malaysia announced that it had agreed to buy 12.8 million doses of the vaccine, becoming the first country in Southeast Asia to reach an agreement with the US pharmaceutical.
Under the agreement, Pfizer will deliver the first million doses in the first quarter of 2021, with 1.7 million, 5.8 million and 4.3 million doses in the following quarters.
Trade Minister Mohamed Azmin Ali said the government is also in talks with other pharmaceutical companies to secure more vaccines.
“The government is making efforts to obtain a greater supply of vaccines to meet our needs. The government will follow the advice of the Ministry of Health regarding the percentage of people who need to be vaccinated,” said Mohamed Azmin, quoted by Bernama.
Pfizer and its German partners BioNTech have supply agreements with several countries, including the United States, Germany, Japan, Canada, Australia, and Great Britain.
They expect to produce up to 50 million doses of vaccines globally in 2020 and up to 1.3 billion doses in 2021.
More than 150 potential vaccines are being developed and tested globally to stop the COVID-19 pandemic, with 48 in human trials, says the WHO.
[ad_2]
